Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Income from Continuing Operations (2022 - 2025)

Bioregenx's Income from Continuing Operations history spans 4 years, with the latest figure at 1017805.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 1017805.0 for Q4 2025, up 94.47% from a year ago — trailing twelve months through Dec 2025 was 1543569.0 (up 92.51% YoY), and the annual figure for FY2025 was 1543569.0, up 93.3%.
  • Income from Continuing Operations for Q4 2025 was 1017805.0 at Bioregenx, down from 80565.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 2191.0 in Q3 2022 to a low of 18400571.0 in Q4 2024.
  • The 4-year median for Income from Continuing Operations is 204091.5 (2023), against an average of 1449116.56.
  • The sharpest move saw Income from Continuing Operations plummeted 26695.74% in 2024, then soared 94.47% in 2025.
  • Year by year, Income from Continuing Operations stood at 5535.0 in 2022, then tumbled by 12907.52% to 719966.0 in 2023, then crashed by 2455.76% to 18400571.0 in 2024, then soared by 94.47% to 1017805.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 1017805.0, 80565.0, and 178345.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.